| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.308 | 31.941 | 46.787 | 55.831 | 68.757 | 98.591 | 108.712 | 135.832 |
| Total Income - EUR | - | - | 6.308 | 31.941 | 46.787 | 55.831 | 68.757 | 98.591 | 108.712 | 136.428 |
| Total Expenses - EUR | - | - | 299 | 5.075 | 18.556 | 19.931 | 20.249 | 25.017 | 22.530 | 21.879 |
| Gross Profit/Loss - EUR | - | - | 6.008 | 26.866 | 28.231 | 35.899 | 48.507 | 73.574 | 86.182 | 114.550 |
| Net Profit/Loss - EUR | - | - | 5.819 | 26.352 | 27.763 | 35.375 | 47.834 | 72.607 | 85.117 | 110.539 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Syomed Neuroclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 109 | 107 | 0 | 0 | 0 | 857 | 782 | 706 |
| Current Assets | - | - | 5.938 | 30.789 | 31.008 | 38.652 | 52.846 | 27.394 | 37.372 | 33.032 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 2.398 | 2.391 | 1.415 |
| Receivables | - | - | 571 | 3.743 | 4.933 | 1.268 | 0 | 4.974 | 13.587 | 20.204 |
| Cash | - | - | 5.367 | 27.046 | 26.075 | 37.384 | 52.846 | 20.022 | 21.394 | 11.412 |
| Shareholders Funds | - | - | 5.863 | 27.273 | 27.814 | 35.425 | 47.882 | 24.843 | 33.005 | 28.766 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 183 | 3.623 | 3.194 | 3.227 | 4.964 | 3.408 | 5.150 | 4.971 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Syomed Neuroclinic Srl